lobbying_activities: 1515984
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1515984 | 2cabbd76-3b80-42d4-ac66-dbdd9c419201 | Q1 | W STRATEGIES, LLC | 400605842 | 23ANDME, INC. | 2014 | first_quarter | MED | Issues relating to regulation of Direct to Consumer (DTC) Genetic Testing and education and outreach regarding genetic testing and personalized medicine, including FDA regulation of DTC tests. Education about Department of Health and Human Services (HHS) final rule amending the Clinical Laboratory ImprovementAmendments of 1988 (CLIA) regulations allowing patients and patient-designated representatives access to laboratory test reports directly from the laboratory at his or her request. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-15T10:10:46.793000-04:00 |